RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Immunomodulatory Therapy Trials in Type 1 Diabetes
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 8
SP 33
OP 34
DO 10.1177/155989771108019
UL http://mdc.sagepub.com/content/11/8/33.abstract
AB As type 1 diabetes continues to be a worldwide epidemic, researchers persist in exploring new ways to prevent the disease from developing or to delay its development, especially in young children. Several studies have evaluated the safety and efficacy of immunomodulatory therapies, both as prevention strategies and as interventions for new-onset disease.